Breaking Finance News

Amyris Inc (NASDAQ:AMRS) target bumped up to $2.80, issued a ratings update earlier today by Singluar Research

Only yesterday Amyris Inc (NASDAQ:AMRS) traded 0.16% higher at $0.50. The company’s 50-day moving average is $0.43 and its 200-day moving average is $0.64. The last stock price is down -23.26% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the date range. Trade Volume was down over the average, with 1,103,807 shares of AMRS changing hands under the typical 2,569,990

Stating a potential upside of 4.6%, Singluar Research increased the price target of Amyris Inc (NASDAQ:AMRS) to $2.80

Previously on Tuesday September 06, 2016, Zacks Investment Research reported about Amyris Inc (NASDAQ:AMRS) raised the target price from $0.00 to $0.50. At the time, this indicated a possible upside of 0.22%.

Recent Performance Chart

Amyris Inc (NASDAQ:AMRS)

Amyris Inc has with a one year low of $0.31 and a one year high of $2.57 and has a market capitalization of $0.

A total of 2 brokerages have issued a ratings update on Amyris Inc. zero brokerages rating the company a strong buy, one brokerage rating the company a buy, two brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $3.25.

General Company Details For Amyris Inc (NASDAQ:AMRS)

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.